kabutan

Oncolys BioPharma surges on European patent intention notice for endoscopic administration of OBP-301

Thu May 28, 2026 9:18 am JST Catalyst

Oncolys BioPharma Inc. <4588> rebounded sharply. After the market close on May 27, the company announced it received a notice of intention to grant a patent from the European Patent Office (EPO) for the endoscopic administration of its pipeline oncolytic virus candidate OBP-301, a disclosure that attracted buying interest. The notice indicates the EPO's decision to grant a European patent based on the current application. Following the approval, ONCOLYS plans to expand its patent protection network, targeting major European markets including the United Kingdom, France, and Germany.

Source: MINKABU PRESS

*Translated by generative AI. Click here for the original article.

Related Articles